Rockwell Medical Technologies (RMTI) Tops Q3 EPS by 1c

Go back to Rockwell Medical Technologies (RMTI) Tops Q3 EPS by 1c

BTIG Affirms Rockwell Medical Tech (RMTI) at 'Buy'; Still Sees as Undervalued with Two Approved Product

November 8, 2016 1:31 PM EST

BTIG affirms Rockwell Medical Technologies (Nasdaq: RMTI) at Buy with a price target of $12 after the company posted Q3 results on Monday night.

Analyst Ling Wang summarized: Rockwell Medical reported 3Q16 EPS of $(0.09) vs. consensus of $(0.10) and our estimate of $(0.11),... More

BofA/Merrill Lynch Downgrades Rockwell Medical Technologies (RMTI) to Underperform

November 8, 2016 7:09 AM EST

BofA/Merrill Lynch downgraded Rockwell Medical Technologies (NASDAQ: RMTI) from Neutral to Underperform with a price target of $5.00.

For an analyst ratings summary and ratings history on Rockwell Medical Technologies click here. For more ratings news on Rockwell Medical Technologies click here.

Shares of Rockwell Medical Technologies closed at $5.66 yesterday.

... More